Alan R. Smyth
Derby Road, NG7 2UH
Nottingham, ENG, United Kingdom
Nottingham, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 174 publications
Interventions for the eradication of meticillin-resistant Staphylococcus aureus (MRSA) in people with cystic fibrosis.
Journal: The Cochrane database of systematic reviews
Published: August 27, 2026
Lung transplant in people with cystic fibrosis and nontuberculous mycobacteria infection.
Journal: The Cochrane database of systematic reviews
Published: April 21, 2026
Nutrition and cardiometabolic health in cystic fibrosis: Emerging evidence and research gaps.
Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: April 01, 2026
Maldigestion, dysbiosis, inflammation and dysmotility: a toxic tetrad in the CF gut.
Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: March 25, 2026
Abnormalities of the distal terminal ileum in people with cystic fibrosis assessed using magnetic resonance imaging.
Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: March 25, 2026
Paracetamol, pyrexia, and the prevention of atopy: lessons from PIPPA Tamariki.
Journal: The Lancet. Child & adolescent health
Published: December 28, 2025
Digital technology for monitoring adherence to inhaled therapies in people with cystic fibrosis.
Journal: The Cochrane database of systematic reviews
Published: December 10, 2025
Non-antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis - A systematic review.
Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: October 07, 2025
CF Tummy Tracker: A Cystic Fibrosis-Specific Patient-Reported Outcome Measure for Daily Gastrointestinal Symptom Burden.
Journal: Mayo Clinic proceedings. Digital health
Published: June 26, 2025
A randomised crossover trial of tezacaftor-ivacaftor for gut dysfunction in cystic fibrosis with magnetic resonance imaging (MRI) outcomes: a pilot study.
Journal: NIHR open research
Published: August 13, 2024
A longitudinal study assessing the impact of elexacaftor/tezacaftor/ivacaftor on gut transit and function in people with cystic fibrosis using magnetic resonance imaging (MRI).
Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: July 01, 2024
Last Updated: 09/26/2026